Fig. 3From: The conundrum of metaplastic breast cancer: a single Egyptian institution retrospective 10-year experience (2011–2020)a OS for the whole metaplastic breast cancer cohort. b OS according to the surgery type. c OS according to pathological axillary nodal status. d OS according to NACT. e OS according to the molecular subtype. f OS according to the metaplastic pathological subtype. g OS according to Ki-67(%). h OS according to pT stageBack to article page